Formalin-based fixation and paraffin embedding (FFPE) is a common method to preserve clinical samples, and FFPE tumor samples serve as valuable study materials for clinical and translational medicine ...

Formalin-fixed paraffin embedding (FFPE) is employed in hospitals around the world to preserve and store clinical samples. However, extracting and purifying DNA from FFPE samples presents challenges, ...

Cancer is a generic term for a large group of malignant diseases that can affect any part of the body. It is characterized by invasive, abnormal growth which grows beyond the usual boundaries and ...

What role does formalin-fixed paraffin embedding (FFPE) play in clinical and translational research? Not only a common method of preservation, FFPE also allows researchers to study tissue samples, ...

In order to truly understand cell biology, researchers need easy-to-use tools that preserve the natural complexity of tissues while capturing the nuances of gene and protein expression. Vizgen’s in ...

New Ionic ® FFPE to Pure RNA Kit features simple, automated workflow for higher yields of pure RNA, including mRNA and miRNA, with less than five minutes of hands-on time per sample PLEASANTON, Calif.

BGI Tech Solutions Co., Ltd., a subsidiary company of BGI, announced today that they have achieved whole exome sequencing analysis of total degraded DNA as low as 200 ng from formalin fixed paraffin ...

Gene expression analysis is emerging as a new diagnostic tool in transplant pathology, in particular for the diagnosis of antibody-mediated rejection. Diagnostic gene expression panels are defined on ...

Rising Incidence of Cancer: An increase in cancer cases globally is driving demand for advanced diagnostic equipment such as FFPE tissue samples, which are crucial for cancer research and diagnostics.

PLEASANTON, Calif.--(BUSINESS WIRE)--Purigen Biosystems, Inc., a leading provider of next-generation technologies for extracting and purifying nucleic acids from biological samples, today announced ...

MENLO PARK, Calif. and WOBURN, Mass., April 15, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, and Covaris, a PerkinElmer ...